LOWER-DOSE SOLUMATRIX® INDOMETHACIN EFFICACY IN ACUTE PAIN: RESULTS FROM TWO PHASE 3 STUDIES

被引：0
|
作者：
Altman, R. [1 ]
Gibofsky, A. [2 ]
Parenti, D. [3 ]
Young, C. [3 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Hosp Special Surg, New York, NY 10021 USA
[3] Iroko Pharmaceut LLC, Philadelphia, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.5286
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0336
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [41] Sensitivity analyses show additional efficacy of indomethacin submicron particle capsules in a phase 3 study in patients experiencing acute pain following elective surgery
    Jaros, M.
    Nezzer, J.
    Solorio, D.
    Young, C.
    JOURNAL OF PAIN, 2014, 15 (04): : S76 - S76
  • [42] Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
    Baraliakos, Xenofon
    Deodhar, Atul
    van der Heijde, Desiree
    van den Bosch, Filip
    Magrey, Marina
    Maksymowych, Walter P.
    Tomita, Tetsuya
    Xu, Huji
    Massow, Ute
    Vaux, Tom
    Prajapati, Chetan
    Manente, Myriam
    Marten, Alexander
    Gensler, Lianne S.
    RHEUMATOLOGY, 2025,
  • [43] Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies
    McInnes, Iain B.
    Mease, Philip J.
    Tanaka, Yoshiya
    Gossec, Laure
    Husni, M. Elaine
    Kristensen, Lars Erik
    Warren, Richard B.
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Gottlieb, Alice B.
    ACR OPEN RHEUMATOLOGY, 2024, 6 (11) : 720 - 731
  • [44] Efficacy and safety of migalastat, an oral pharmacologic chaperone for Fabry disease: results from two randomized phase 3 studies, FACETS and ATTRACT
    Feldt-Rasmussen, Ulla
    Giugliani, Roberto
    Germain, Dominique P.
    Hughes, Derralynn A.
    Wilcox, William R.
    Schiffmann, Raphael
    Bichet, Daniel G.
    Jovanovic, Ana
    Bratkovic, Drago
    Castelli, Jeffrey P.
    Yu, Julie
    Skuban, Nina
    Barth, Jay A.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S45 - S46
  • [45] BIMEKIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Thaci, Diamant
    Gottlieb, Alice B.
    Asahina, Akihiko
    Lebwohl, Mark
    McInnes, Iain B.
    Warren, Richard
    Boehncke, Wolf-Henning
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Merola, Joseph F.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [46] Phase 1b Study of Lower-Dose CPX-351 Plus Venetoclax As First-Line Treatment for Patients with AML Who Are Unfit for Intensive Chemotherapy: Preliminary Safety and Efficacy Results
    Uy, Geoffrey L.
    Pullarkat, Vinod A.
    Baratam, Praneeth
    Stuart, Robert K.
    Faderl, Stefan
    Chandrasekaran, Vijayalakshmi
    Wang, Qi
    Chakravarthy, Divya
    Cheung, Ronald S.
    Lin, Tara L.
    BLOOD, 2021, 138
  • [47] Sustained efficacy of lasmiditan: Results from phase 3 randomized clinical trials for acute treatment of migraine
    Doty, E. G.
    Krege, J.
    Jin, L.
    Raskin, J.
    Singh, R. Halker
    Kalidas, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 139 - 139
  • [48] Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies
    Mease, Philip J.
    Deodhar, Atul
    Dougados, Maxime
    Dubreuil, Maureen
    Magrey, Marina
    Marzo-Ortega, Helena
    Rudwaleit, Martin
    De la Loge, Christine
    Ellis, Alicia
    Fleurinck, Carmen
    Oortgiesen, Marga
    Taieb, Vanessa
    Gensler, Lianne
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 810 - 813
  • [49] Efficacy results from a phase 3, randomized, placebo-controlled trial testing two doses of linzagolix in women with endometriosis-associated pain
    Dolmans, M. M.
    Becker, C. M.
    Petraglia, F.
    Donnez, J.
    Boolell, M.
    Bestel, E.
    HUMAN REPRODUCTION, 2023, 38
  • [50] Efficacy and Safety of Ipilimumab in Patients with Metastatic Melanoma: Summary of Results from two Ipilimumap Phase III Studies
    Schadendorf, D.
    Becker, J.
    Garbe, C.
    Hauschild, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 778 - 779
12345